Researchers Harness AI to Repurpose Existing Drugs for Treatment of Rare Diseases September 25, 2024 New AI model identifies drug candidates from existing medicines for thousands of rare diseases
George Q. Daley Delivers 2024 State of the School Speech September 23, 2024 Dean describes magnetic pull of research, education, service
Harvard Medical School Researcher Wins 2024 Lasker Award for Work That Led to GLP-1 Therapies September 19, 2024 Joel Habener, fellow scientists honored for discoveries paving the way to GLP-1 based treatments
Training Inventors of Future Medicines September 6, 2024 New educational opportunities immerse HMS students in drug discovery and development
Awards & Recognitions: July 2024 August 5, 2024 Honors received by HMS faculty, postdocs, staff, and students
New Strategy for Preventing Relapse After CAR T-Cell Therapy August 2, 2024 Booster treatment improved long-term immune therapy success in models of multiple myeloma
What Will the New Cardiovascular Risk Calculator Mean for Patients? July 29, 2024 Analysis forecasts more heart attacks and strokes as fewer people become eligible for meds
Five Harvard Medical School Faculty Named HHMI Investigators July 23, 2024 Award helps basic researchers and physician-scientists pursue their boldest ideas
Awards & Recognitions: June 2024 July 7, 2024 Honors received by HMS faculty, postdocs, staff, and students
Providing Ethical Guidance when Translating Science into Technology June 25, 2024 Collaborative ethics aims to ensure safety and benefit for everyone
2024 Warren Alpert Prize Honors Four Pioneers in CAR T-Cell Therapy June 11, 2024 Lab-made immune cells offer a lifeline for patients with blood cancers
A Step Toward New Solutions for Inflammatory Pain June 5, 2024 Clues may lie in interactions between immune cells and pain-sensing neurons
